SynergenX, rapidly-growing leader in optimized hormone health and weight loss, is commemorating America's 250th anniversary with its "250 for 250" initiative, a limited-time promotion designed to make personalized testosterone replacement therapy (TRT) and hormone replacement therapy (HRT) more accessible while encouraging men and women to invest in their long-term health.

Throughout July, eligible new male and female patients who begin TRT at a SynergenX, Low T Center, or HerKare clinic and remain on treatment for 90 days will receive a $250 account credit.

"At SynergenX, we believe innovative healthcare should also be accessible healthcare," said Wayne Wilson, Founder and CEO of SynergenX. "This initiative reflects our commitment to helping more men address the symptoms of low testosterone through personalized, provider-led care that improves quality of life."

Low testosterone can impact energy, mental clarity, mood, body composition, and sexual health for both men and women. SynergenX providers use comprehensive evaluations, advanced diagnostics, and ongoing monitoring to develop individualized treatment plans tailored to each patient's unique physiology and health goals.

With 64 SynergenX, HerKare, and Low T Center clinics across 10 states, the organization continues to expand access to evidence-based hormone optimization, women's hormone replacement therapy, peptide therapy, medical weight loss, and primary care. Every location is guided by the same commitment to clinical excellence, personalized medicine, and exceptional patient care.

The "$250 for 250" initiative reflects SynergenX's broader mission to improve health outcomes by making advanced, personalized care more accessible to the communities it serves.

The promotion is available to eligible new TRT patients who begin treatment between July 1 and July 31, 2026, continue therapy for 90 days, and will automatically receive a $250 account credit in November.

About SynergenX

SynergenX and Low T Center operate 64 clinics across 10 states, providing personalized care for testosterone replacement therapy, women's hormone replacement therapy, peptide therapy, medical weight loss, primary care, and wellness. Through provider-led, evidence-based medicine, SynergenX helps patients improve their health, vitality, and quality of life.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260703840343/en/

SynergenX Launches "$250 for 250" Initiative to Expand Access to Personalized TRT